Merit Medical Systems, Inc.
Capital Structure
•
in mil. unless spec.Working Capital
•
in mil. unless spec.Growth Rates
•
in mil. unless spec.Quarterly Revenue
•
in mil. unless spec.Quarterly Earnings Per Share
•
in mil. unless spec.Quarterly Dividends Per Share
•
in mil. unless spec.Company Description
- CEO
- Martha Goldberg Aronson
- Full Time Employees
- 7,500
- Sector
- Health technology
- Industry
- Medical specialties
- Address
- 1600 West Merit Parkway South Jordan UT United States 84095
- IPO Date
- Sep 16, 1954
- CIK
- 0000856982
- Website
- merit.com
- Similar Companies
- Business
- Merit Medical Systems, Inc. is a leading worldwide designer, developer, manufacturer, and marketer of proprietary disposable medical devices used in interventional, diagnostic, and therapeutic procedures, particularly in cardiology, radiology, oncology, critical care, and endoscopy. Founded in 1987 and headquartered in South Jordan, Utah, the company operates in two primary segments, Cardiovascular and Endoscopy, offering a broad portfolio of products including micropuncture kits, angiographic needles, sheaths, guidewires, safety devices, inflation devices for angioplasty and stent placement, diagnostic and therapeutic catheters, thrombolytic catheters, fluid dispensing systems, angiography accessories, hemostatic solutions, and procedural kits for peripheral intervention, spine, and oncology applications; it serves hospitals, physicians, and clinicians globally with approximately 7,000 employees and manufacturing facilities worldwide. In May 2025, Merit acquired Biolife Delaware, L.L.C. for approximately $120 million in cash and assumed liabilities, adding the patented StatSeal and WoundSeal hemostatic products that address a $350 million global market opportunity and are projected to contribute $18 million in annual revenue starting in fiscal 2026; earlier transactions include the November 2024 acquisition of assets from Cook Medical Holdings LLC and the July 2024 acquisition of EndoGastric Solutions, Inc., alongside a signed asset purchase agreement in October 2025 for the C2 CryoBalloon from PENTAX Medical to expand its gastroenterology portfolio.
Company News
Here's Why You Should Retain MMSI Stock in Your Portfolio for Now
Critical Review: Merit Medical Systems (NASDAQ:MMSI) and Olympus (OTCMKTS:OCPNY)
HSIC vs. MMSI: Which Stock Should Value Investors Buy Now?
Merit Medical Presents Real-World Data from the AVF Cohort of the WRAP Global Registry
These Analysts Boost Their Forecasts On Merit Medical Systems After Strong Q3 Results
Merit Medical Systems, Inc. (MMSI) Q3 2026 Earnings Call Transcript
Merit Medical Systems Q3 Earnings Call Highlights
Merit Medical (MMSI) Q3 Earnings and Revenues Beat Estimates
Merit Medical (MMSI) Reports Q3 Earnings: What Key Metrics Have to Say
Merit Medical Reports Third Quarter 2026 Results: Delivers 9% Organic Constant Currency Revenue Growth and Raises Full-Year 2026 Guidance
Merit Medical Acquires Solo Pace, Inc., Expanding Its Cardiac Therapies Platform with Innovative TAVR Pacing Technology
Here Are Wednesday’s Top Wall Street Analyst Research Calls: Enphase Energy, F5, Marvell Technology, MSG Rangers, Pentair, Silicon Motion Technology, Spotify Technology, Texas Instruments, Whirlpool, and More
Conestoga Small Cap Composite Q3 2026 Portfolio Activity
Cancer Stocks to Consider as Oncology Innovation Accelerates
Merit Medical Systems to Announce Third Quarter 2026 Results on October 29, 2026
HSIC or MMSI: Which Is the Better Value Stock Right Now?
Here's Why You Should Add Merit Medical Stock to Your Portfolio Now
5 Medical Dental Supply Stocks to Watch as Industry Prospects Improve
Financial Survey: Merit Medical Systems (NASDAQ:MMSI) vs. Bausch + Lomb (NYSE:BLCO)
Merit Medical to Participate in Upcoming Investors Conferences in September